Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Monthly Brain Cycles Predict Epilepsy Seizures

By HospiMedica International staff writers
Posted on 17 Jan 2018
A new study suggests it may soon be possible to know when epilepsy patients are at highest risk for seizures by identifying monthly cycles of brain activity.

Researchers at the University of California, San Francisco (UCSF; USA), the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), and other institutions conducted a study in 37 subjects previously implanted with the NeuroPace (Mountain View, CA, USA) RNS brain stimulation system in an attempt to define the relationship of seizure timing to fluctuating rates of interictal epileptiform activity (IEA), a marker of brain irritability observed between seizures by electroencephalography (EEG).

The study found that IEA oscillates with circadian and subject-specific multidien (multi-day) periods. More...
The multidien periodicities, most commonly 20–30 days in duration, were found to be robust and relatively stable for up to 10 years in both men and women, and that the seizures occured preferentially during the rising phase of IEA rhythms. By combining the phase information from circadian and multidien IEA rhythms, a novel biomarker for determining relative seizure risk is available in most subjects. The study was published on January 8, 2017, in Nature Communications.

“One of the most disabling aspects of having epilepsy is the seeming randomness of seizures. If your neurologist can't tell you if your next seizure is a minute from now or a year from now, you live your life in a state of constant uncertainty, like walking on eggshells,” said senior author Vikram Rao, MD, PhD, of UCSF. “The exciting thing here is that we may soon be able to empower patients by letting them know when they are at high risk and when they can worry less.”

“I like to compare it to a weather forecast; in the past, the field has focused on predicting the exact moment a seizure will occur, which is like predicting when lightning will strike; that's pretty hard,” concluded Dr. Rao. “It may be more useful to be able tell people there is a five percent chance of a thunderstorm this week, but a ninety percent chance next week. That kind of information lets you prepare.”

The NeuroPace RNS system is designed to detect the brain’s electrical activity. When it identifies seizure activity, it attempts to suppress the seizure by sending electrical stimulation through implanted leads to the brain. A physician-operated programmer communicates with the RNS, allowing stored information to be reviewed. An optional data transmitter can provide the physician with the information in real-time, so that the response to the stimulation can be evaluated to decide on the best seizure detection and stimulation settings for the patient.

Related Links:
University of California, San Francisco
Wyss Center for Bio and Neuroengineering
NeuroPace

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.